Is Teva Pharmaceutical a value opportunity? Ole Søeberg's IVIC pitch

Описание: During the International Value Investing Conference 2018 Ole Søeberg from Nordic Investment Partners gave a presentation von Teva Pharmaceutical. The company is a global pharmaceutical company, which is headquartered in Israel.

Founded by Ole Søeberg in 2017, Nordic Investment Partners offers investment advice and a GARP fund investment for selected investors. Investment philosophy: stocks are inefficiently priced and the inefficiency varies in magnitude and timing. Valuation is at the core of the investment decision process. Fund focus with only 20 stocks and a peer/pipeline of approx. 100 stocks. Focus on companies that are determined to grow from their core with a clear strategy and aligned with shareholders. The fund due diligence process includes the traditional assessment as well as understanding of the culture, people and competitive moat. Small –and mid-sized companies offer the best long-term potential and are carefully balanced with portfolio liquidity.

Ole Søeberg on LinkedIn:   / ole-s%c3%b8eberg-9211905  
Nordic Investment Partners: http://nordic-investment-partners.com/

#valueinvesting #teva #ivic18

Mehr | More
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
💻 Homepage: https://www.valuedach.de/ - English: https://www.valuedach.com/
📩Newsletter: https://www.valuedach.de/kontakt/valu...
👥 LinkedIn:   / valuedach  
🐥 twitter:   / valuedach  
📸 Instagram:   / valuedach  
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬

Disclaimer:
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
Deutsch: https://www.valuedach.de/impressum/di...
English: https://www.valuedach.de/en/imprint/d...
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬